The metabotropic gamma-amino-butyric acid B receptor (GABABR) is a G protein-coupled receptor that mediates neuronal inhibition by the neurotransmitter GABA. Here, we identified putative GABAB receptors and signaling modulators in the basal sea anemone Nematostella vectensis. Activation of GABABR signaling reversibly arrests planula-to-polyp transformation during early development and affects the neurogenic program. We identified four Nematostella GABABR homologs that have the conserved 3D extracellular domains and residues needed for binding of GABA and the GABABR agonist baclofen. Transcriptomic analysis, combined with spatial analysis of baclofen-treated planulae, revealed that baclofen down-regulated pro-neural factors such as NvSoxB (2), NvNeuroD1 and NvElav1. Baclofen also inhibited neuron development and extended neurites, resulting in an under-developed and less organized nervous system. Our results shed light on cnidarian development and suggest an evolutionarily conserved function for GABABR in regulation of neurogenesis, highlighting Nematostella as a new model system to study GABABR signaling. 
Introduction
-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in both vertebrates and invertebrates, playing a key role in modulating neuronal activity. GABA activity is mediated by two distinct receptors -the ionotropic GABAA and the metabotropic GABAB receptors. The GABAA receptor is a chloride ion channel that mediates fast synaptic inhibition. The GABAB receptor (GABABR) is a G-protein-coupled receptor (GPCR) that produces prolonged and slow synaptic inhibition through second messengers and modulation of calcium (Ca 2+ ) and potassium (K + ) channels. These receptors function as obligatory heterodimers composed of GABAB1 and GABAB2 subunits, with both subunits required for their function (1) (2) (3) . GABA binds to a large Venus flytrap (VFT) structural module in the extracellular portion of the GABAB1 monomer (4, 5) , whereas GABAB2 does not bind GABA, but activates the coupled G protein and enhances ligand affinity via interactions with the GABAB1 monomer (6) (7) (8) (9) (10) . The VFT module is not unique to GABAB1R and can be found in diverse proteins, ranging from other GPCRs and ion channels in eukaryotes and periplasmic binding proteins in prokaryotes (11) . During embryonic development, GABABR plays important roles in mammalian neuronal proliferation, migration and network formation (12) (13) (14) (15) . In adults, in addition to a general role in inhibiting neurotransmission, GABABR signaling is also an important inhibitor of neuronal differentiation, controlling stem and progenitor cell proliferation (16, 17) .
Although GABAB receptors have been extensively studied in mammalian model organisms and in Drosophila and C. elegans (18-21), little is known on their function in non-bilaterian animals.
Cnidaria are the phylogenetic sister group to Bilateria and one of the earliest-branching metazoan taxa that possess a nervous system (22) . Other early metazoans, such as Placozoa and Porifera, possess genes related to sensory transmission, yet lack neurons and synapses, while Ctenophora harbor a nervous system of unclear homology to cnidarian and bilaterian systems (23) (24) (25) .
Moreover, this lineage is missing most of the Bilateria classical neurotransmitters, including GABA (26) . By contrast, cnidarians possess a diffuse nervous system that contains three primary types of neuronal cells: sensory neurons, ganglion neurons, and cnidocytes, the stinging cells that characterize the phylum (27, 28) . Their phylogenetic placement and simple nerve-net structure make them an attractive model for exploring basic neurogenic processes. 3 Among the cnidarians, the sea anemone Nematostella vectensis has become an important model system, with a published genome and available genetic tools (29, 30) . During its simple life cycle, an embryo develops into a larval stage of a swimming planula, which metamorphoses into a primary polyp that eventually gives rise to the mature polyp (31) . Despite its relatively simple bodyplan, analysis of the Nematostella genome has revealed an unexpected complexity and extensive conservation of vertebrate genomic content and organization (30) . This similarity is also reflected in a conserved neuronal gene repertoire, which includes orthologous genes associated with cholinergic, glutamatergic, and aminergic neurotransmission (27, (32) (33) (34) . Genes putatively related to GABA signaling were identified in Nematostella using large-scale phylogenetic analysis (32) . GABA itself was shown to accumulate early in Nematostella planulae in the aboral pole and in ectodermal neurons (34) . However, the role of GABA during development or in neurogenesis is unknown and the specific receptors that mediate GABA signaling have not been characterized.
In this study, we demonstrated that Nematostella has four putative GABAB1R genes. The extracellular domains of these genes are predicted to have a homologous 3D structure to mammalian GABAB1R and contain conserved residues that can mediate agonist binding. Using baclofen, a GABABR-specific agonist, we elucidated the role of GABA-mediated signaling during Nematostella early development. Our findings showed that baclofen arrested planula-topolyp transformation and inhibited neurogenesis; yet, the effect was reversible. These results suggest a conserved role for GABA signaling in controlling neuronal network formation in the basal sea anemone and highlights future uses for Nematostella as a model organism to study GABA-mediated signaling.
Results

GABA B receptors play a role in planula-to-polyp transformation
The morphogenetic transition of Nematostella planulae into primary polyps occurs 7 to 12 days post-fertilization (dpf). Since GABA was found to accumulate in early Nematostella planulae (34), we tested the effect of GABA on planula-to-polyp transformation. We found that addition of GABA (10 -3 M) at 3 dpf, at the early planula stage, prevented metamorphosis of more than 4 85% of the planulae, while about 80% of control planulae metamorphosed by 8 dpf (Fig. 1a) . A lower GABA concentration (10 -4 M) reduced the rate of metamorphosis, but did not inhibit the process, probably due to natural GABA degradation (Fig. 1a) . Arrested planulae continued to develop to the late planula stage, although their development was much slower than untreated control planulae (Fig. 1b) . To identify which GABA receptor family is involved in the inhibition of transformation, we tested the effect of GABAAR and GABABR agonists. We found that the GABAAR agonist muscimol (10 -4 M) demonstrated toxic and lethal effects, inhibiting further development of early planulae (data not shown). By contrast, the GABAB1R agonist baclofen (10 -4 M) had a similar physiological effect as GABA, but inhibited metamorphosis to a larger degree (Fig. 1a) . Additionally, CGP-7930, a GABAB2R positive allosteric modulator (35) , prevented metamorphosis in more than 60% of the planulae and the affected planulae had a similar morphology as GABA-or baclofen-treated planulae (Fig. 1b) . Baclofen-treated planulae did not transform to primary polyps, but their body structure, marked by F-actin, displayed a similar pattern to control untreated planulae ( Supplementary Fig. 1 ). However, in control oral poles, tentacles emerged and elongated around the oral opening, whereas in GABA/baclofen/CGP-7930-treated planulae tentacle growth was arrested (Fig. 1b) .
Because oralization and tentacle induction were previously shown to be controlled by the Wnt pathway (36, 37), we tested the expression of specific Wnt ligands that were shown to characterize the oral pole of Nematostella planulae (38). We found that the expression levels and oral localization of NvWntA, NvWnt1, NvWnt3, NvWnt5 and NvWnt11 did not change following baclofen treatment ( Supplementary Fig. 2 ) suggesting that the inhibitory effect of GABABR signalling is not mediated through changes in the expression of Wnt ligands.
In addition, planulae treated with baclofen exhibited similar apical tufts as control planulae ( Supplementary Fig. 1 ), an organ that was suggested to play a role during Nematostella metamorphosis (39, 40) . Yet, in control planulae the apical tuft was lost during metamorphosis, whereas in baclofen-treated planulae it remained. The effects of GABA, baclofen and CGP-7930 were reversible, as removal of these compounds on 7 dpf restored metamorphosis and enabled the planulae to develop into primary polyps (Fig. 1a) . However, the addition of GABABR antagonists such as saclofen, phaclofen and CGP-54626 had no detectable effect on planulae development or metamorphosis rates (data not shown). These results suggest that a unique 5 GABABR homolog, which is resistant to known antagonists, mediates the effect of GABA on planula-to-polyp transformation.
Identification and characterization of Nematostella GABA B receptors
To identify Nematostella GABAB receptors, we searched all Nematostella proteins in the NCBI RefSeq database using the sequences of human GABAB1 and GABAB2 receptors as queriesboth with the full length proteins and with the N-terminal extracellular domain and the transmembrane regions separately. Putative Nematostella GABABR homologs were used as queries against the Uniprot database to confirm homology; indeed, the top hits for all identified genes were GABABR genes. This search identified eight candidates GABABR homologs in Nematostella. Seven of these genes appeared in a large genomic survey of chemical transmission-related genes (32): four genes (v1g244104, v1g239821, v1g206093, v1g243252) had full sequences, but three other homologs had only partial sequences (see Methods for details). We, therefore, fully sequenced the four partial or new genes, which were assigned the following NCBI identifiers: MH194577-79 and MH355581.
The GABABR homologs we identified contained the conserved domains expected of a functional GABAB receptor (Fig. 2 ). These included a signal peptide, followed by a large extracellular Nterminal domain that contains the structural VFT module that binds GABA, as well as seven trans-membrane (TM) domains that are characteristic of G protein-coupled receptors. Predicted coiled-coil motifs, which are found in the human GABABR where they mediate heterodimerization and receptor trafficking (41, 42) , were predicted in only three Nematostella homologs. In general, the intracellular C-terminus portion of the Nematostella homologs had low similarity to the corresponding human sequences.
Six of these homologs had the same global domain arrangement as human GABABR. One Nematostella homolog (v1g206093) contained two extracellular domains, each corresponding to a separate predicted VFT module. These two domains are 26% identical in sequence, suggesting that they have dissimilar function (Supplementary Fig. 3 ). Another homolog, v1g243252, had eight predicted TM helices (predicted by three different prediction servers, see Materials and Methods) and a ~300 residue domain of unknown function (DUF4475) located after these TM domains.
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To test if the identified GABABR homologs exhibit neuronal-related expression, we searched the recently published Nematostella cell type expression atlas (43) , quantifying the expression of the eight GABABR homologs ( Supplementary Fig. 4 ). We detected all eight homologs in this single cell analysis, although MH194578 and MH194579 were expressed at extremely low levels and did not show any cell type specificity, while MH355581 was expressed at low levels and only in a specific group of cells of the gastrodermis. In contrast, four of the GABABR homologs (MH194577, v1g244104, v1g239821, and v1g206093) were expressed in neuronal cell clusters, including in larval neurons. On the other hand, v1g243252 was identified only in adult digestive filaments -this non-neural expression, together with its divergent protein architecture, suggested it is not a GABABR homolog that can mediate the phenotypes observed above.
Unlike many GPCRs, the GABA binding site is located exclusively in the extracellular VFT domain of the GABAB1R. However, the VFT module can be found in many proteins that do not bind GABA (11) . Therefore, to assess the ability of these candidate homologs to act as functional GABA-binding receptors, we compared their extracellular domains to their bilaterian homologs.
Using multiple sequence alignments and the 3D structures of human GABAB1R, we analyzed the conservation of residues shown previously as critical for ligand binding. This comparison revealed that only four sequences had both the homologous scaffold structure and the conserved residues needed for agonist binding, while the other four sequences were either missing essential structural and binding residues or had an insertion that was predicted to interfere with agonist binding ( Fig. 3 and Supplementary Fig. 3 ).
Initially, we marked which conserved residues determine a 3D scaffold for ligand binding in vertebrate GABAB1R. The crystal structure of the VFT extracellular domain of human GABAB1R consists of two lobe-shaped domains (LB1 and LB2) that close upon ligand binding. This structure is stabilized by two conserved disulfide bridges, Cys103-Cys129 and Cys259-Cys293 ( Fig. 3 ), which were shown to be essential for a functional GABA-binding structure in the GABAB1R (5). Five Nematostella proteins (MH194577-79, MH355581 and v1g244104) contain four cysteines that correspond to all of these disulfide bridge-forming residues, whereas the other three homologs (v1g239821, v1g206093, and v1g243252) were missing cysteines that correspond to Cys103 and Cys129 -these three proteins are therefore predicted not to bind GABA ( Fig. 3 and Supplementary Fig. 3 ).
In the human GABAB1R, Trp65, Ser130, Ser153, Tyr250 and Gly151 were identified previously as critical mediators of GABA binding (4, 5) . Among the five Nematostella proteins, MH194577-79 and MH355581 contain identical residues or conserved substitutions in the corresponding positions, whereas v1g244104 had a large and positively-charged arginine in the position that corresponds to Ser153. Such a dramatic substitution will interfere with agonist binding via both steric and electrostatic interactions, suggesting that v1g244104 will not bind GABA or its analogs. In addition, the γ-amino group of agonists such as GABA or baclofen forms hydrogen bonds with Tyr250 in LB2 and His170 and Glu349 in LB1. All Nematostella GABABR homologs contained a tyrosine residue in the corresponding position to Tyr250 and had a conserved tyrosine residue that the 3D modeling showed could substitute for Glu349 (Fig.   3 ). Since His170 was not conserved in any of the Nematostella GABAB proteins, we suggest that His170 is dispensable for agonist binding. Taken together, these results predict that four Nematostella homologs, MH194577-79 and MH355581, contain functional GABA and baclofen binding sites and we therefore suggest that they are functional GABAB1R homologs.
We also analyzed the conservation of GABAB1R residues that were shown to mediate antagonist binding to human GABAB1R. Several human GABAB1R residues, such as Gly64, Ser131, Ser154, Val159, and Met 312, were suggested to mediate specific interactions with GABAB1R
antagonists. While Gly64, Ser154 and Val159 were conserved in all Nematostella homologs, Ser131 was conserved only in MH194577 and was substituted by the similarly-sized alanine in MH355581. However, residues in Nematostella homologs that correspond to Met312 were not conserved, and the entire LB1 loop, in which Met 312 is located, was also not conserved ( Fig. 3 ).
Comparing the structure of the extracellular domain of human GABAB1R bound to the antagonist CGP54626 (4) with the predicted 3D structure of the corresponding domain in Nematostella showed that the first and the fifth loops in the predicted LB1 were longer by several amino acids than the corresponding loops in human GABAB1R (Fig. 4) . These longer loops will most likely result in a substantially smaller binding pocket in the Nematostella homologs. Given that antagonists of GABAB1R are larger than the agonists of this receptor, we suggest that the smaller binding pocket of Nematostella homologs will prevent binding of these specific antagonists, explaining our experimental results. 
Transcriptome analysis
To identify genes and pathways involved in GABABR signaling and in metamorphosis inhibition by the GABA agonist baclofen, we used a whole-transcriptome RNA-seq approach. Having observed no morphological difference in the inhibitory effects of baclofen at 3 dpf or 4 dpf, we analyzed samples from planulae at different time points from 4 dpf until 6 dpf, just before metamorphosis begins (Fig. 5a ). Samples were analyzed at 2 h, 24 h and 48 h after baclofen addition. Because our metamorphosis experiments showed that the effect of baclofen on planulae was reversible (Fig. 1) , we also sampled planulae 2 h and 24 h after baclofen removal. Control planulae were sampled at corresponding time points (Fig. 5a ). On average, 15.77 million sequence reads were obtained for each sample. We continued with analysis of only differentially expressed transcripts (see Materials and Methods). Across all treatments, more than 10,000 transcripts displayed significant changes in gene expression (Supplementary Table 1 ). To examine the effect of the treatments over time, we explored the transcriptomic data using nonmetric multidimensional scaling analysis (nMDS). This analysis showed clear differences between the transcriptomes of control and baclofen-treated planulae during the time of development (Fig. 5b) . In addition, removal of baclofen dramatically affected the planula transcriptome within 2 h and, after additional 24 h, the transcriptome of washed planulae differed further from those of both baclofen-treated and control planulae (Fig. 5b) . To demonstrate the effect of baclofen treatment together with changes in planulae developmental, we compared expression in different time points using an MA plot analysis (Fig. 5c,d ). This revealed transcripts that changed significantly during development (at 24 h and 48 h) in both control and baclofen-treated planulae, as well as transcripts that significantly changed only with baclofen. Therefore, baclofen treatment did not arrest the planulae developmental plan, but had a specific affect that resulted in planulae-to-polyp transformation.
Autoregulation of GABA biosynthesis
Since baclofen is not metabolized in the cell in comparison to GABA, we postulated that the prolonged activation of the GABABR pathway by baclofen would reduce the biosynthesis of GABA. Therefore, we tested for changes in expression of putative homologs that are relevant to this pathway. Indeed, we found that the expression of the glutamate transporter homologs EAAT1, EAAT3 and EAAT5, which in vertebrate carry the GABA substrate glutamate into the 9 presynaptic cell, as well as the expression of four homologs of glutamic acid decarboxylases (GADs), which decarboxylate glutamate into GABA, were down regulated in planulae treated with baclofen (Fig. 6a,b) . Furthermore, genes coding for enzymes that degraded GABA or reuptake GABA from the synaptic cleft, such as GABA-transaminase (GABA-T), GABA transporter 1 (GAT1) and inhibitory vesicle transporters (vGATs), were upregulated in the presence of baclofen. A second GABA transporter homolog, GAT2, was down regulated in baclofen-treated planulae. Interestingly, tumor susceptibility gene 101 (TSG101), which is a component of the ESCRT (endosomal sorting complex required for transport) complex and is involved in GABABR degradation in vertebrates (44) (45) (46) , was up regulated following baclofen addition and down regulated following baclofen wash. We also found that three GABAA receptor subunits were down regulated after 48h baclofen treatment as well as one GABAB (v1g239821) receptor. However, the expression level of all the other GABAB subunits did not change. The finding of down-regulation of GABA synthesis pathways and up-regulation of GABA degradation pathways imply that GABA levels will be reduced in baclofen-treated planulae.
Indeed, testing GABA spatial accumulation in control and baclofen-treated planulae demonstrated strong GABA reduction in treated planulae (Fig. 6c,d ). These results suggest the presence of functional GABA signaling and of GABA regulatory pathways in Nematostella, where baclofen activates a GABABR dependent signaling pathway and triggers a specific autoregulation response that includes inhibition of GABA synthesis and activation of GABA removal and degradation.
GABA signaling inhibits planula neurogenesis
Next, we examined the effect of prolonged GABABR activation on early development of the nervous system of planulae. Transcriptomic analysis revealed significant down regulation in baclofen-treated planulae of pro-neural transcription factors such as NvSoxB (2), NvAshA, NvAthlike, NvNeuroD1, NvOtxB, NvSoxC, and NvBrn2, of two neuron-specific RNA-binding proteins,
NvElav1
and NvMsi, and of other neuronal genes (Supplementary Table 1 ). Spatial expression analysis of key neurogenic transcription factors in control and baclofen-treated planulae demonstrated that while their expression levels decreased, their expression patterns did not change (Fig. 7a,b ). An exception to this down regulation trend was NvSoxB1 that initially, in the transcriptomic data, was down regulated in baclofen-treated planulae and then up regulated to a similar expression level as in the control (Fig. 7a,b) .
We further tested a transgenic line expressing mOrange under the promotors of NvElav1.
Addition of baclofen reduced NvElav1gene expression, resulting in a less organized neural net that lacked the longitudinal neurons along the mesenteries, forming a less dense mesh-like structure, specifically in the oral pole (Fig. 7c,d) . In untreated planulae Elav positive neurons are elongated in the ectoderm of the oral pole creating a "crown like" structure that is absent in baclofen-treated planulae. The cnidarian nervous system also includes the stinging cells known as cnidocytes; therefore, we also analyzed genes specifically expressed during cnidogenesis (Fig.   7a) . Expression of mini-collagen 3 (NvMc3), a structural protein in the stinging capsule, is extremely reduced in baclofen-treated planulae, as was expression of NvPaxA, a member of the homeodomain transcription factors family that is required for cnidocyte development (47) .
The substantial down regulation of key positive regulators of neural differentiation following baclofen treatment indicated that prolonged activation of GABABR signaling inhibits neurogenesis. Thus, we expected to find less differentiated neurons in baclofen-treated planulae.
To test this hypothesis, we performed immunostaining with an antiRF-amide neuropeptide antibody. We compared untreated planulae at 4 and 5 dpf to planulae treated with baclofen for 24 h or 48 h. At early planula stages, RF-amide-positive neurons were found in the ectodermal layer ( Fig. 7e-h ). As the planula grows, these neurons form a net throughout the ectoderm and endoderm with high density in the oral region (Fig. 7i-n) . We detected RF-amide neurons at the ectoderm layer in both control and baclofen-treated planulae. However, a significant decrease in these RF-amide neurons was observed 24 h after baclofen treatment (Fig. 7f,h ). Following neural differentiation at 5 dpf, control planulae exhibited extended neurites connecting the neurons in both ectoderm and endoderm layers, as well as the presence of basiepithelial neurites that connect the ectodermal neurons (Fig. 7i,k,m) . By contrast, in 5 dpf planulae following 48 h of baclofen treatment, only a few neurons developed neurites and these were relatively short.
Additionally, only a few basiepithelial neurites were observed and no connections between RFamide neurons in the ectoderm were seen (Fig. 7j,l,n) . Hence, we conclude that the GABABR signaling pathway inhibits neuron formation and nervous system development in Nematostella.
Discussion
In this study, we demonstrated that activation of GABABR by either a specific agonist or by a positive allosteric modulator inhibited planula-to-polyp transformation. This effect was reversible and showed no toxicity, while removal of GABABR modulators led to a continuation of the Nematostella developmental plan. Interestingly, in other marine invertebrate such as molluscs and sea urchins, GABA was suggested to play a role in metamorphosis, either as an inducer or as an inhibitor, but receptors mediating these effects have not been characterized nor additional GABA signaling components have been implicated (48) (49) (50) . In contrast, our characterization of putative Nematostella GABABR homologs identified four genes with all the conserved features of a functional GABAB1R. The cysteines shown to form disulfide bridges that are essential for a functional GABABR VFT extracellular domain (5) are conserved in all four putative GABAB1R Nematostella homologs, as were residues that are essential for a binding site for GABA and GABA agonists.
Our analysis also suggested that Nematostella GABAB1R proteins have smaller GABA binding pockets that will not accommodate the larger GABABR antagonists. Indeed, we found that the latter had no effect on Nematostella planula-to-polyp transformation. Interestingly, in the cnidarian freshwater hydra, GABABR agonists and antagonists were shown to affect the feeding response, but receptors responsible for this phenotype have not been characterized (51, 52) .
However, such differences in the ability of GABAB1 receptors to bind agonists or antagonists were also found in other species, despite the high conservation of previously characterized GABAB1R homologs among vertebrates and invertebrates. For example, baclofen had no effect in D. melanogaster and in C. elegance, and highly effective antagonists for mammalian GABAB1R had no effect in Drosophila (19, 53) .
In addition to the identification of GABAB1R homologs, we also showed a functional connection to broader GABA regulation pathways. Baclofen affected the expression of diverse enzymes in GABA metabolism, reducing GABA biosynthesis and transport and increasing GABA removal and degradation -suggesting a functional autoregulated GABA signaling system in Nematostella. Since we found that several GABAA receptors were also down regulated following baclofen application, this supports cross-talk between GABAB and GABAA signaling, as was suggested before in mammalian systems (54) .
As the main inhibitory neurotransmitter in metazoans, GABA is an essential part of the mammalian nervous system. It was demonstrated that in the mammalian brain, activation of GABABR promote quiescence of neural stem cells and inhibition of neurogenesis (13, 16, 17) .
Our results suggest an evolutionarily conserved function in Nematostella, as baclofen activation of GABABR inhibited expression of pro-neuronal genes and neurogenesis. Additionally, there was a significant decrease in the Elav-and RF-amide neuron population and in the development of neurites in baclofen-treated planulae. We also found that genes related to cnidocyst synthesis and regulation were down-regulated following baclofen treatment, which is in line with previous finding in hydra, suggesting that GABABR play a role in cnidocyst discharge (51) . However, unlike the sustained transcriptomic down regulation of neuron related genes after baclofen addition, NvSoxB1 expression quickly recovered to a level similar to control planulae. In Bilateria, the SoxB family is divided into two subgroups: SoxB1 and SoxB2, which have antagonizing functions -controlling neuron stem cell maintenance and neuron differentiation 
Methods
Sea anemone culture
Anemones were cultured in Nematostella medium (NM) composed of 12.5 ppt artificial sea water (Red Sea, Israel) maintained at 18°C in the dark. Anemones were fed 5 times a week with freshly hatched Artemia brine shrimps. Mature Sea anemones were induced to spawn as described (67) . Embryos were raised at 21°C in the dark and planulae or polyps were collected for the different experiments.
Pharmaceutical treatments
Treatments were done in triplicates, with each plate containing approximately 100 planulae. M, Sigma Aldrich) was used to test whether GABAA receptor play a role in metamorphosis.
Identification and cloning of Nematostella GABA B receptors
To uncover Nematostella homologs of human GABABR we searched with the sequences of human GABAB1bR (NP068703) and GABAB2R (CAA09942) using blastp all Nematostella proteins in the NCBI RefSeq database. Putative identified homologs were used as queries against the UniProt database to confirm homology. In addition, we also searched for Nematostella homologs with the N-terminal extracellular region and the transmembrane regions of the human queries separately, using both the blastp and tblastn options. The following four Nematostella full sequences were identified: v1g244104, v1g239821, v1g206093, v1g243252. Full length sequences of the three previously identified partial Nematostella GABAB1R homologs (v1g86565, v1g158857, v1g87697) and a newly identified homolog (v1g210496) were PCRamplified using the following primers (with NCBI identifiers): 5', ATGTCAAGTGTCGGAGCTATTG and 3', TCACTCTTTTGATTGCATCGGAC for 
Domain predictions and three-dimensional structural analysis
Nematostella putative GABABR genes were translated to proteins using the ExPASy online translate tool (http://web.expasy.org/translate). Sequence conservation was visualized using the We generated 3D models of the extracellular regions of NvGABAB proteins using Swiss-model (https://swissmodel.expasy.org) (68) using the crystal structure of the extracellular domain of human GABABR -PDB ID 4MS4 (4). The following protein data bank (PDB) crystal structures were used: 4MS3, structure of the extracellular domain of human GABABR bound to the endogenues agonist GABA; 4MS4, structure of the extracellular domain of human GABABR bound to the agonist baclofen; 4MR7, structure of the extracellular domain of human GABABR bound to the antagonist CGP54626. Visualization of the 3D models was done using the PyMOL Molecular Graphics System (https://pymol.org).
RNA extraction, sequencing and bioinformatics analysis
Transcriptome experiments were done on 4 dpf baclofen-treated (10 (69) . 72%-75% of all reads were mapped uniquely, and ~15% were mapped to multiple loci. Differential expression analysis was conducted using DESeq2 (70) . Transcript abundances were represented as FPKMs (fragments per kilobase million), and significance was defined as adjusted p-value < 0.05. Expected factor-dependent trends were verified using non-metric multidimensional scaling (NMDS) graphs in Vegan (https://github.com/vegandevs/vegan). Heatmaps were generated using shinyheatmap (http://shinyheatmap.com) (71)based on Ward's hierarchical clustering, considering FPKM-based Euclidean distances between genes.
In situ hybridization and immunohistochemistry
Whole-mount in situ hybridization (ISH) was done according to (72) and immunohistochemistry was performed according to (73) . The following primary antibodies were used: anti-GABA 
Microscopy and imaging
In situ hybridization was visualized using a Zeiss Axio Imager 2 epifluorescence microscope equipped with an AxioCam MRm camera (Carl Zeiss, Jena, Germany). Immunofluorescent was visualized using confocal microscopy (Nikon, C1-SHS UMT). Planulae were visualized using a Nikon binocular (Multizoom Az-100) or Nikon eclipse Ti. Identical residues are marked in black and conservatively substituted residues are marked in gray. Residues involved in both agonist and antagonist binding are marked in red, residues involved in agonist binding only are marked in magenta, residues predicted to be involved in agonist binding are marked in bordeaux and residues involved in antagonist binding only are marked in orange. Cysteines showed to form disulfide bridges (S) that stabilize the VFT domain and are critical for GABA binding are marked in green. Secondary structure elements of human GABAB1R are displayed above the alignment: α-helices are shown as cylinders and β-strands as arrows, colored purple and cyan in the LB1 and LB2 sub-domains of the extracellular VFT domain, respectively. Bilaterian sequences accession numbers: human (Hs), NP_068703; rat (Rn), AAD19657; mouse (Mn), AAH56990; Drosophila (DM), AAF53431; C. elegans (Ce), ACE63490 and Nematostella (Nv) sequences: Nv_GABAB1a, MH194577; Nv_GABAB1b, MH194578; Nv_GABAB1c, MH194579; Nv_GABAB1d, MH355581. EAAT1_132063  EAAT5_132052  EAAT3_230013  GAD_208016  GAD_70058  GAD_60834  GAD_60452  GAT2_247614  vGAT_214632  GABA A _204447  GABA A _201724  GABA A _127934  GABA A _111552  GABA B2 R_239821  Cac-L_88037  Cac-L_127874  Cac-T_170705  TSG101_244032  GAT1_236066  vGAT_241391  vGAT_96724  vGAT_241392 labelled with an anti-mCherry antibody. Note the less organized Elav-expressing neuron net in baclofen-treated planulae, specifically in the oral part (marked with arrows). e-h Confoca l sections of 4 dpf control planulae (e,g) and baclofen-treated planulae (f,h) labeled with antibodies against RF-amide (red), phalloidin (green) and DAPI (blue). Note that RF-amid neurons are organized in the ectoderm. i-n, Confocal sections of 6 dpf control planulae (i,k,m) and baclofentreated planulae (j,l,n) labeled with anti-RF-amide antibody (white). The areas marked with white rectangles in i and j are magnified in k and l respectively. Note the long and developed neurites (marked with yellow arrows) in control planulae (k,m) versus baclofen treated-planulae (l,n), which have few and short neurites. Oral side is facing up in all images or labeled with asterisk. ecectoderm; en-endoderm; Scale bars, 50 µm. 
